Regional Growth West is expanding its manufacturing footprint in Singapore, China, and India to support local demand in Asia-Pacific. This creates opportunities to partner on regional supply of injectable containment and drug delivery components, provide local warehousing and logistics, and assist with regulatory aligned manufacturing solutions for Asian markets.

Growth Momentum With reported quarterly revenue near $845 million and year over year growth of about 21% with organic growth of 15.3%, West demonstrates strong demand for injectable solutions. This backdrop supports multi year procurement contracts, volume based pricing, and upselling higher value containment and delivery devices across global customers.

Leadership Transition Michel Lagarde has been named CEO effective August 31, 2026, succeeding the long time CEO. Use this timing to propose strategic alliances, co development initiatives, and joint go to market plans aligned with West growth priorities and technology investments.

Cyber Resilience West disclosed material cyberattacks in May 2026 that disrupted operations. This signals a high value opportunity to offer cybersecurity risk management, secure data integration with SAP and IBM Maximo, and business continuity solutions to ensure uninterrupted supply of critical injectable components.

Global Scale With 50 sites and a workforce of 5,001 to 10,000 across a global footprint, West serves billions of components and devices annually. This scale favors collaboration on manufacturing automation, ERP SAP PLM integrations, and co innovation on next generation packaging and delivery systems to meet rising demand and complex regulatory requirements.